Cleared Traditional

K924083 - 700/700-1

K924083 is an FDA 510(k) clearance for 700/700-1, manufactured by Citicare Systems, Inc.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 209-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1993
Decision
209d
Days
Class 2
Risk

K924083 is an FDA 510(k) clearance for the 700/700-1. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Citicare Systems, Inc. (Milwaukee, US). The FDA issued a Cleared decision on March 10, 1993 after a review of 209 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Citicare Systems, Inc. devices

FDA 510(k) Submission Details - K924083

510(k) Number K924083 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 13, 1992
Decision Date March 10, 1993
Days to Decision 209 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
69d slower than avg
Panel avg: 140d · This submission: 209d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 256
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K924083.
NELLCOR STAT-CAP AIRWAY CO2 INDICATOR, MODEL N-60
K915494 · Nellcor, Inc. · Aug 1993
RASCAL II
K930866 · Ohmeda Medical · May 1993
CAPNOMED 100 STAND-ALONE ETCO2 MODULE
K920915 · Mennen Medical, Inc. · Mar 1993
MASS SPECTROMETRY MONITORING LINE CONONECTORS
K925167 · Merit Medical Systems, Inc. · Jan 1993
BATTERY PACKS
K923305 · Access / God Loves You · Dec 1992
VITALERT 3000 MONITORING SYSTEM
K913995 · Draeger Medical, Inc. · Nov 1992